Disputes conclusions in Hildenbrand study.
Zollman
C
C
Rees
R
R
D000529:Complementary Therapies; D006801:Humans; D008545:Melanoma / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D015996:Survival Rate